Andrea L. Kasinski

Publications

• Histone 4 Lysine 20 Tri-methylation: a Key Epigenetic Regulator in Chromatin Structure and Disease
  Frontiers in Genetics. 2023  |   Pubmed ID: 37671044
• A First-in-class Fully Modified Version of MiR-34a with Outstanding Stability, Activity, and Anti-tumor Efficacy
  Oncogene. Sep, 2023  |   Pubmed ID: 37666938
• Emerging Diversity in Extracellular Vesicles and Their Roles in Cancer
  Frontiers in Oncology. 2023  |   Pubmed ID: 37397375
• In-Cell Western Protocol for Semi-High-Throughput Screening of Single Clones
  Bio-protocol. Aug, 2022  |   Pubmed ID: 36199701
• Loss of KMT5C Promotes EGFR Inhibitor Resistance in NSCLC Via LINC01510-Mediated Upregulation of MET
  Cancer Research. Apr, 2022  |   Pubmed ID: 35404406
• Author Correction: Extracellular Vesicles Released by Non-small Cell Lung Cancer Cells Drive Invasion and Permeability in Non-tumorigenic Lung Epithelial Cells
  Scientific Reports. Feb, 2022  |   Pubmed ID: 35165361
• Extracellular Vesicles Released by Non-small Cell Lung Cancer Cells Drive Invasion and Permeability in Non-tumorigenic Lung Epithelial Cells
  Scientific Reports. Jan, 2022  |   Pubmed ID: 35046472
• Ligand-mediated Delivery of RNAi-based Therapeutics for the Treatment of Oncological Diseases
  NAR Cancer. Sep, 2021  |   Pubmed ID: 34316717
• MicroRNA-34a: Potent Tumor Suppressor, Cancer Stem Cell Inhibitor, and Potential Anticancer Therapeutic
  Frontiers in Cell and Developmental Biology. 2021  |   Pubmed ID: 33763422
• Identification of MicroRNAs That Promote Erlotinib Resistance in Non-small Cell Lung Cancer
  Biochemical Pharmacology. Jul, 2021  |   Pubmed ID: 32681833
• InVivo Cancer-Based Functional Genomics
  Trends in Cancer. Dec, 2020  |   Pubmed ID: 32828714
• Combatting PDAC with Two Tumor-targeting Small RNAs
  Oncotarget. Oct, 2019  |   Pubmed ID: 31666921
• Identification and Validation of MicroRNAs That Synergize with MiR-34a - a Basis for Combinatorial MicroRNA Therapeutics
  Cell Cycle (Georgetown, Tex.). Aug, 2019  |   Pubmed ID: 31258013
• Enhancing MicroRNA Activity Through Increased Endosomal Release Mediated by Nigericin
  Molecular Therapy. Nucleic Acids. Jun, 2019  |   Pubmed ID: 31071527
• New Mechanism for Release of Endosomal Contents: Osmotic Lysis Via Nigericin-Mediated K/H Exchange
  Bioconjugate Chemistry. Apr, 2018  |   Pubmed ID: 29446616
• MicroRNA-223 Suppresses the Canonical NF-κB Pathway in Basal Keratinocytes to Dampen Neutrophilic Inflammation
  Cell Reports. Feb, 2018  |   Pubmed ID: 29444433
• No Vehicle, No Problem
  Oncotarget. Nov, 2017  |   Pubmed ID: 29228541
• Animal Models to Study MicroRNA Function
  Advances in Cancer Research. 2017  |   Pubmed ID: 28882225
• FolamiRs: Ligand-targeted, Vehicle-free Delivery of MicroRNAs for the Treatment of Cancer
  Science Translational Medicine. Aug, 2017  |   Pubmed ID: 28768807
• Targeting Adhesion Signaling in Mutant Lung Adenocarcinoma
  JCI Insight. Mar, 2017  |   Pubmed ID: 28289710
• Sulforhodamine B (SRB) Assay in Cell Culture to Investigate Cell Proliferation
  Bio-protocol. Nov, 2016  |   Pubmed ID: 28573164
• MicroRNAs in Cancer: A Historical Perspective on the Path from Discovery to Therapy
  Cancers. Jul, 2015  |   Pubmed ID: 26226002
• RNA-guided CRISPR-Cas Technologies for Genome-scale Investigation of Disease Processes
  Journal of Hematology & Oncology. Apr, 2015  |   Pubmed ID: 25888285
• A Combinatorial MicroRNA Therapeutics Approach to Suppressing Non-small Cell Lung Cancer
  Oncogene. Jul, 2015  |   Pubmed ID: 25174400
• Aberrant Regulation and Function of MicroRNAs in Cancer
  Current Biology : CB. Aug, 2014  |   Pubmed ID: 25137592